image of a green circle Annotated and expert reviewed. Please contact us if you can help with updates. 

Kir3.2

Family: Inwardly rectifying potassium channels

Contents:
Gene and Protein Information
Previous and Unofficial Names
Database Links
Associated Proteins
Ion Selectivity and Conductance
Activators
Gating Inhibitors
Pore Blockers
Tissue Distribution
Physiological Functions
Phenotypes, Alleles and Disease Models
Clinically-Relevant Mutations and Pathophysiology
Gene Expression and Pathophysiology
Biologically Significant Variants
References
Gene and Protein Information
Species TM P Loops AA Chromosomal Location Gene Symbol Gene Name Reference
Human 2 1 423 21q22.13-22.2 KCNJ6 potassium inwardly-rectifying channel, subfamily J, member 6 4,30
Mouse 2 1 425 16 C4 Kcnj6 potassium inwardly-rectifying channel, subfamily J, member 6 1,20
Rat 2 1 425 11q11 Kcnj6 potassium inwardly-rectifying channel, subfamily J, member 6 34
Previous and Unofficial Names
GIRK2
hiGIRK2
KATP-2
BIR
Kir3.2
KCNJ7
KATP2
BIR1
GIRK-2
Kcnj6_predicted
LOC360252
G protein-activated inward rectifier potassium channel 2
Potassium inwardly-rectifying channel subfamily J member 6
inward rectifier K(+) channel Kir3.2
potassium channel, inwardly rectifying subfamily J member 6
potassium inwardly-rectifying channel, subfamily J, member 6
potassium inwardly-rectifying channel, subfamily J, member 6 (predicted)
wv
Database Links
DrugBank Target 1581 (Hs)
Ensembl ENSG00000157542 (Hs), ENSMUSG00000043301 (Mm), ENSRNOG00000001658 (Rn)
Entrez Gene 3763 (Hs), 16522 (Mm), 25743 (Rn)
GeneCards KCNJ6 (Hs)
GenitoUrinary Development Molecular Anatomy Project Kcnj6 (Mm)
HomoloGene 1688 (Hs)
Human Protein Reference Database 02929 (Hs)
InterPro P48051 (Hs), P48542 (Mm), P48550 (Rn)
KEGG Gene hsa:3763 (Hs), mmu:16522 (Mm), rno:25743 (Rn)
OMIM 600877 (Hs)
PharmGKB Gene PA30049 (Hs)
PhosphoSitePlus P48051 (Hs), P48542 (Mm)
Protein Ontology (PRO) PRO:000002003 (Hs)
RefSeq Nucleotide NM_002240 (Hs), NM_010606 (Mm), NM_001025584 (Mm), NM_001025590 (Mm), NM_001025585 (Mm), NM_013192 (Rn)
RefSeq Protein NP_002231 (Hs), NP_001020756 (Mm), NP_001020761 (Mm), NP_001020755 (Mm), NP_034736 (Mm), NP_037324 (Rn)
TreeFam ENSG00000157542 (Hs), ENSMUSG00000043301 (Mm), ENSRNOG00000001658 (Rn)
UniGene Hs. 658533 (Hs)
UniProt P48051 (Hs), P48542 (Mm), P48550 (Rn)
Wikipedia Kir3.2
Potassium channels
Search for 3D structures on the PDB
Search by keyword: Inwardly rectifying potassium channels Kir3.2 Search by accession number: P48542, P48550, P48051
Associated Proteins
Heteromeric Pore-forming Subunits
Name References
Kir3.4 21
Kir3.3 10,17,35
Kir3.1 17,21
Auxiliary Subunits
Name References
Not determined
Other Associated Proteins
Name References
Gβγ 17
Associated Protein Comments
The Kir3.1/3.2 channel is the major functional assembly in the brain [21].
Ion Selectivity and Conductance
Species:  Mouse
Rank order:  K+ [30.0 pS]
References:  17
Ion Selectivity and Conductance Comments
Kir3.2 forms functional heteromers with Kir3.3 (31pS, [10]).
Activators
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Affinity Units Concentration range (M) Holding voltage (mV) Reference
ethanol ? - - 1x10-2 - 2x10-1 -120.0 – -70.0 13,22
PIP2 ? 6.3 pKd 5x10-5 Physiological 5-6
Na+ Hs 1.6 pEC50 - -80.0 5
View species-specific activator tables
Activator Comments
Kir3.2 is also activated by Gβγ subunits [17].

The studies of the action of phosphatidylinositol 4,5-bisphosphate, Na+ and ethanol were performed using Kir3.1/3.2 heteromers.
Gating inhibitors
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Affinity Units Concentration range (M) Holding voltage (mV) Reference
pimozide Mm 5.53 pEC50 - -70.0 14
thioridazine Mm 4.2 pEC50 - -70.0 14
haloperidol Mm 4.1 pEC50 - -70.0 14
clozapine Mm 3.75 pEC50 - -70.0 14
SCH-23390 Hs 4.08 – 5.11 pIC50 - -60.0 19
fluoxetine Mm 4.05 – 4.77 pIC50 - -70.0 15
halothane ? 4.2 pIC50 - -70.0 37
bupivacaine ? 4.0 – 4.2 pIC50 - -110.0 – -40.0 41
F3 ? 4.1 pIC50 - -80.0 39
verapamil Mm 3.92 pIC50 - -100.0 18
MK-801 Mm 3.7 pIC50 - -100.0 18
View species-specific gating inhibitor tables
Gating Inhibitor Comments
The following references encompass data regarding the Kir3.1/3.2 heteromer: [14-15,19,37,39,41].

Kir3.2 is also inhibited by Gαi subunits[28]. RGS (regulators of G-protein signalling) proteins accelerate GTP hydrolysis of Gαsubunits, so that they increase the amount of GDP-bound Gα subunits, thus reducing the numbers of Gα-free Gβγ subunits [3,29].
Pore Blockers
Key to terms and symbols View all chemical structures Click column headers to sort
Ligand Sp. Affinity Units Concentration range (M) Holding voltage (mV) Reference
clomipramine Mm 4.4 pIC50 - -70.0 16
desipramine Mm 4.4 pIC50 - -70.0 16
imipramine Mm 4.3 pIC50 - -70.0 16
amitriptyline Mm 4.0 pIC50 - -70.0 16
maprotiline Mm 4.0 pIC50 - -70.0 16
nortriptyline Mm 3.9 pIC50 - -70.0 16
QX-314 Mm 3.7 pIC50 - - 18
Pore Blocker Comments
The following references encompass data regarding the Kir3.1/3.2 heteromer: [16]
Tissue Distribution
Testis.
Species:  Mouse
Technique:  Immunocytochemistry
References:  7
Cortex, lateral septal nucleus, hippocampus, cerebellum, substantia nigra, ventral tegmental area.
Species:  Mouse
Technique:  Immunohistochemistry
References:  23
Hippocampus, substantia nigra, pontine nucleus, cerebellar granular layer, olfactory bulb, cerebral cortex, septum, amygdala.
Species:  Mouse
Technique:  In situ hybridisation, RT-PCR
References:  8,12
Pancreas.
Species:  Rat
Technique:  In situ hybridisation
References:  33
Olfactory bulb, neocortex, hippocampus, amygdala, substantia nigra, thalamus, vestibular nucleus, cochlear nucleus.
Species:  Rat
Technique:  In situ hybridisation
References:  11
Cotex, lateral septal nucleys, hippocampus, cerebellum, substantia nigra, ventral tegmental area.
Species:  Rat
Technique:  Immunohistochemistry
References:  8,23
Physiological Functions
Kir3.2 participates in the formation of the slow inhibitory postsynaptic potential and probably in the presynaptic inhibition in the brain.
Species:  Rat
Tissue:  Brain.
References:  8,31
In the endocrine organs, neurotransmitters induce hyperpolarisation of the membrane potential and lead to the inhibition of hormone secretion.
Species:  Rat
Tissue:  Pancreas, pituitary.
References:  24,40
Kir3.2d may be involved in spermatogenesis.
Species:  Mouse
Tissue:  Testis.
References:  7,27
Phenotypes, Alleles and Disease Models Mouse data from MGI

Click here to show/hide data

Allele Composition & genetic background Accession Phenotype Id Phenotype Reference
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J		 MGI:104781  MP:0003091 abnormal cell migration PMID: 2723742 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6J		 MGI:104781  MP:0003091 abnormal cell migration PMID: 2723742 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0004097 abnormal cerebellar cortex morphology PMID: 11596045 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J		 MGI:104781  MP:0004097 abnormal cerebellar cortex morphology PMID: 4118891 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J-Kcnj6		 MGI:104781  MP:0004098 abnormal cerebellar granule cell morphology PMID: 3882972 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6		 MGI:104781  MP:0004098 abnormal cerebellar granule cell morphology PMID: 8855331 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J		 MGI:104781  MP:0000886 abnormal cerebellar granule layer PMID: 2723742  4118891 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0000886 abnormal cerebellar granule layer PMID: 9520333 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0000886 abnormal cerebellar granule layer PMID: 9520333 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0000886 abnormal cerebellar granule layer
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0006097 abnormal cerebellar lobule formation PMID: 11596045 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J		 MGI:104781  MP:0000889 abnormal cerebellar molecular layer PMID: 2723742 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0000889 abnormal cerebellar molecular layer PMID: 9520333 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6J		 MGI:104781  MP:0000889 abnormal cerebellar molecular layer PMID: 2723742 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0000889 abnormal cerebellar molecular layer
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0000875 abnormal cerebellar Purkinje cell layer PMID: 11596045 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0000875 abnormal cerebellar Purkinje cell layer PMID: 11596045 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J		 MGI:104781  MP:0000875 abnormal cerebellar Purkinje cell layer PMID: 4118891 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0000875 abnormal cerebellar Purkinje cell layer PMID: 9520333 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0000875 abnormal cerebellar Purkinje cell layer
Kcnj6tm1Stf|Kcnj6wv Kcnj6tm1Stf/Kcnj6wv
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J		 MGI:104781  MP:0000875 abnormal cerebellar Purkinje cell layer PMID: 9023358 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0000854 abnormal cerebellum development
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0000872 abnormal cerebellum external granule cell layer morphology PMID: 9520333 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0000872 abnormal cerebellum external granule cell layer morphology
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J		 MGI:104781  MP:0000849 abnormal cerebellum morphology PMID: 2723742  4118891 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0000849 abnormal cerebellum morphology PMID: 8081012 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6J		 MGI:104781  MP:0000849 abnormal cerebellum morphology PMID: 2723742 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J		 MGI:104781  MP:0000864 abnormal cerebellum vermis morphology PMID: 2723742 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6J		 MGI:104781  MP:0000864 abnormal cerebellum vermis morphology PMID: 2723742 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6		 MGI:104781  MP:0002206 abnormal CNS synaptic transmission PMID: 8855331 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6		 MGI:104781  MP:0006333 abnormal cochlear nucleus morphology PMID: 2077109 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0003243 abnormal dopaminergic neuron morphology PMID: 7062116 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0002631 abnormal epididymis morphology PMID: 8081012 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0001406 abnormal gait
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J * CBA		 MGI:104781  MP:0002761 abnormal hippocampal mossy fiber morphology PMID: 8574680 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J * CBA		 MGI:104781  MP:0008284 abnormal hippocampus pyramidal cell layer PMID: 8574680 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBA A/A-Kcnj6		 MGI:104781  MP:0001765 abnormal ion homeostasis PMID: 10766925 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0003313 abnormal locomotor activation PMID: 7062116 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6J		 MGI:104781  MP:0001392 abnormal locomotor activity PMID: 9023358 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBA A/A-Kcnj6		 MGI:104781  MP:0006362 abnormal male germ cell morphology PMID: 7760215 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
B6CBA A/A-Kcnj6		 MGI:104781  MP:0006362 abnormal male germ cell morphology PMID: 7760215 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0001386 abnormal maternal nurturing
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J-Kcnj6		 MGI:104781  MP:0002066 abnormal motor capabilities/coordination/movement
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0001516 abnormal motor coordination/ balance
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0003632 abnormal nervous system morphology PMID: 7062116 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6		 MGI:104781  MP:0002204 abnormal neurotransmitter level PMID: 6127146 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0003964 abnormal noradrenaline level PMID: 6123371 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0008572 abnormal Purkinje cell dendrite morphology PMID: 11596045 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0008572 abnormal Purkinje cell dendrite morphology PMID: 11596045 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0000877 abnormal Purkinje cell morphology PMID: 11596045 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J		 MGI:104781  MP:0000877 abnormal Purkinje cell morphology PMID: 4118891 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBA A/A-Kcnj6		 MGI:104781  MP:0006304 abnormal seminiferous epithelium morphology PMID: 7760215 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
B6CBA A/A-Kcnj6		 MGI:104781  MP:0006304 abnormal seminiferous epithelium morphology PMID: 7760215 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBA A/A-Kcnj6		 MGI:104781  MP:0002216 abnormal seminiferous tubule morphology PMID: 7760215 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0002216 abnormal seminiferous tubule morphology PMID: 8081012 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBA A/A-Kcnj6		 MGI:104781  MP:0002784 abnormal Sertoli cell morphology PMID: 7760215 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBA A/A-Kcnj6		 MGI:104781  MP:0006380 abnormal spermatid morphology PMID: 10766925 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
B6CBA A/A-Kcnj6		 MGI:104781  MP:0006380 abnormal spermatid morphology PMID: 7760215 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBA A/A-Kcnj6		 MGI:104781  MP:0001156 abnormal spermatogenesis PMID: 7760215 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
B6CBA A/A-Kcnj6		 MGI:104781  MP:0001156 abnormal spermatogenesis PMID: 7760215 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBA A/A-Kcnj6		 MGI:104781  MP:0002674 abnormal sperm motility PMID: 7760215 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
B6CBA A/A-Kcnj6		 MGI:104781  MP:0002674 abnormal sperm motility PMID: 7760215 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0000836 abnormal substantia nigra morphology PMID: 7062116 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6J		 MGI:104781  MP:0000836 abnormal substantia nigra morphology PMID: 9023358 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6		 MGI:104781  MP:0004494 abnormal synaptic glutamate release PMID: 6127146 
Kcnj6tm1Stf|Kcnj9tm1Kwn Kcnj6tm1Stf/Kcnj6tm1Stf,Kcnj9tm1Kwn/Kcnj9tm1Kwn
involves: 129S1/Sv * 129X1/SvJ		 MGI:104781  MGI:108007  MP:0003635 abnormal synaptic transmission PMID: 12040038 
Kcnj6tm1Stf Kcnj6tm1Stf/Kcnj6tm1Stf
involves: 129S1/Sv * 129X1/SvJ		 MGI:104781  MP:0003635 abnormal synaptic transmission PMID: 12040038 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0001146 abnormal testis morphology PMID: 8081012 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0006098 absent cerebellar lobules
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0009268 absent cerebellum fissure
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0001393 ataxia PMID: 11596045 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0001393 ataxia PMID: 8081012  9520333 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0005159 azoospermia PMID: 8081012 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0001265 decreased body size
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0001262 decreased body weight PMID: 11596045 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0001262 decreased body weight
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0005643 decreased dopamine level PMID: 7062116 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0003910 decreased eating behavior
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6		 MGI:104781  MP:0000880 decreased Purkinje cell number PMID: 2077109 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0008770 decreased survivor rate
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0000884 delaminated Purkinje cell layer PMID: 11596045 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J * CBA		 MGI:104781  MP:0010011 ectopic hippocampus pyramidal cells PMID: 8574680 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBACa A/A-Kcnj6/J		 MGI:104781  MP:0000885 ectopic Purkinje cell PMID: 11596045 
Kcnj6tm1Stf Kcnj6tm1Stf/Kcnj6tm1Stf
involves: 129S1/Sv * 129X1/SvJ		 MGI:104781  MP:0009358 environmentally induced seizures PMID: 9023358 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBA A/A-Kcnj6		 MGI:104781  MP:0002686 globozoospermia PMID: 7760215 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0004144 hypotonia PMID: 8081012 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0001523 impaired righting response PMID: 8081012 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0001523 impaired righting response
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6J		 MGI:104781  MP:0006042 increased apoptosis PMID: 2723742 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0006042 increased apoptosis PMID: 9520333 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6J		 MGI:104781  MP:0006042 increased apoptosis PMID: 2723742 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0000879 increased Purkinje cell number
Kcnj6tm1Stf Kcnj6tm1Stf/Kcnj6tm1Stf
involves: 129S1/Sv * 129X1/SvJ		 MGI:104781  MP:0002906 increased susceptibility to pharmacologically induced seizures PMID: 9023358 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0008911 induced hyperactivity
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0008569 lethality at weaning
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0001925 male infertility PMID: 8081012 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6J		 MGI:104781  MP:0001925 male infertility PMID: 9023358 
Kcnj6wv Kcnj6wv/Kcnj6wv
B6CBA A/A-Kcnj6		 MGI:104781  MP:0002687 oligozoospermia PMID: 7760215 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
B6CBA A/A-Kcnj6		 MGI:104781  MP:0002687 oligozoospermia PMID: 7760215 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0002082 postnatal lethality
Kcnj6tm1Stf|Kcnj9tm1Kwn Kcnj6tm1Stf/Kcnj6tm1Stf,Kcnj9tm1Kwn/Kcnj9tm1Kwn
involves: 129S1/Sv * 129X1/SvJ		 MGI:104781  MGI:108007  MP:0002083 premature death PMID: 12040038 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J-Kcnj6		 MGI:104781  MP:0002083 premature death
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0002083 premature death
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0001923 reduced female fertility
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0001922 reduced male fertility
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0010323 retropulsion PMID: 8081012 
Kcnj6tm1Stf|Kcnj9tm1Kwn Kcnj6tm1Stf/Kcnj6tm1Stf,Kcnj9tm1Kwn/Kcnj9tm1Kwn
involves: 129S1/Sv * 129X1/SvJ		 MGI:104781  MGI:108007  MP:0002064 seizures PMID: 12040038 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0001154 seminiferous tubule degeneration PMID: 8081012  9520333 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6		 MGI:104781  MP:0000852 small cerebellum PMID: 6127146 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0000852 small cerebellum PMID: 6123371  8081012  9520333 
Kcnj6+|Kcnj6wv Kcnj6wv/Kcnj6+
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0000852 small cerebellum PMID: 9520333 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0000852 small cerebellum
Kcnj6tm1Stf|Kcnj6wv Kcnj6tm1Stf/Kcnj6wv
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J		 MGI:104781  MP:0006099 thin cerebellar granule layer PMID: 9023358 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0003997 tonic-clonic seizures
Kcnj6tm1Stf Kcnj6tm1Stf/Kcnj6tm1Stf
involves: 129S1/Sv * 129X1/SvJ		 MGI:104781  MP:0003997 tonic-clonic seizures PMID: 9023358 
Kcnj6wv Kcnj6wv/Kcnj6wv
involves: C57BL/6 * CBA/CaGnLe		 MGI:104781  MP:0000745 tremors PMID: 8081012 
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0000745 tremors
Kcnj6wv Kcnj6wv/Kcnj6wv
C57BL/6J		 MGI:104781  MP:0008913 weaving
Clinically-Relevant Mutations and Pathophysiology
Disease:  Weaver mouse
References:  2,26-27,31-32
Click column headers to sort
Type Species Molecular location Description Reference
Missense Mouse G156S 2,27,31
Clinically-Relevant Mutations and Pathophysiology Comments
In the weaver mouse the natural mutation in Kir3.2 permits Na+, as well as K+, ions to pass through the channel [32] and reduces its sensitivity to Gβγ [26]. The weaver mouse experiences spontaneous tonic-clonic seizures.
Gene Expression and Pathophysiology
Kir3.2 knockout mouse.
Tissue or cell type:  Brain
Pathophysiology:  Spontaneous seizures, increased susceptibility to pharmacologically-induced seizures.
Species:  Mouse
Technique:  Knockout
References:  31
Biologically Significant Variants
Kir3.2a. This isoform exists as a channel in heterologous complex with Kir3.1 throughout the brain.
Nucleotide accession:  NM_001025584 
Protein accession:  NP_001020755 
Amino acids:  414
Type:  Splice variant
Species:  Mouse
References:  20,23
Kir3.2a. This protein is specifically expressed in brain and exists as a channel in heterologous complex with Kir3.2c in dopaminergic neurons in the substantia nigra.
Nucleotide accession:  AB073754 
Protein accession:  BAB85221 
Amino acids:  414
Type:  Splice variant
Species:  Rat
References:  8,25,34
Kir3.2b is ubiquitously expressed.
Nucleotide accession:  NM_001025585 
Protein accession:  NP_001020756 
Amino acids:  327
Type:  Splice variant
Species:  Mouse
References:  9
Kir3.2b is ubiquitously expressed.
Nucleotide accession:  AB073756 
Protein accession:  BAB85223 
Amino acids:  327
Type:  Splice variant
Species:  Rat
References:  34
Kir3.2c exists as a heterologous channel in complex with Kir3.1 throughout the brain. In pancreatic α cells Kir3.2c co-expresses with Kir3.4.
Nucleotide accession:  NM_010606 
Protein accession:  NP_034736 
Amino acids:  425
Type:  Splice variant
Species:  Mouse
References:  21,23,40
Kir3.2c exists as a channel in heterologous complex with Kir3.2a in dopaminergic neurons of the substantia nigra.
Nucleotide accession:  NM_013192 
Protein accession:  NP_037324 
Amino acids:  425
Type:  Splice variant
Species:  Rat
References:  8,34
Kir3.2d shows specific expression in testis and behaves as a homomeric channel.
Nucleotide accession:  AB029502 
Protein accession:  BAA88430 
Amino acids:  407
Type:  Splice variant
Species:  Mouse
References:  7
Nucleotide accession:  NM_001025590 
Protein accession:  NP_001020761 
Amino acids:  302
Type:  Splice variant
Species:  Mouse
References: 
Biologically Significant Variant Comments
Distribution of Kir3.2 is related to isoform expression. At least seven exons contribute to producing at least four splice variants [7,36,38]. In the brain some Kir3.2 isoforms exist as complexes, not only with Kir3.1, but also with Kir3.3 [10,35] and Kir 3.4 [21].

REFERENCES

Show »

1. (1988) Bombesin-like peptides in health and disease. Proceedings of an international symposium. October 13-16, 1987, Rome, Italy. A tribute to Vittorio Erspamer, M.D. Ann N Y Acad Sci, 547: 1-541. [PMID:3071214]

2. Adelbrecht, C; Murer, MG; Lauritzen, I; Lesage, F; Ladzunski, M; Agid, Y; Raisman-Vozari, R. (1997) An immunocytochemical study of a G-protein-gated inward rectifier K+ channel (GIRK2) in the weaver mouse mesencephalon. Neuroreport, 8 (4): 969-74. [PMID:9141074]

3. Doupnik, CA; Davidson, N; Lester, HA; Kofuji, P. (1997) RGS proteins reconstitute the rapid gating kinetics of gbetagamma-activated inwardly rectifying K+ channels. Proc. Natl. Acad. Sci. U.S.A., 94 (19): 10461-6. [PMID:9294233]

4. Ferrer, J; Nichols, CG; Makhina, EN; Salkoff, L; Bernstein, J; Gerhard, D; Wasson, J; Ramanadham, S; Permutt, A. (1995) Pancreatic islet cells express a family of inwardly rectifying K+ channel subunits which interact to form G-protein-activated channels. J. Biol. Chem., 270 (44): 26086-91. [PMID:7592809]

5. Ho, IH; Murrell-Lagnado, RD. (1999) Molecular determinants for sodium-dependent activation of G protein-gated K+ channels. J. Biol. Chem., 274 (13): 8639-48. [PMID:10085101]

6. Huang, CL; Feng, S; Hilgemann, DW. (1998) Direct activation of inward rectifier potassium channels by PIP2 and its stabilization by Gbetagamma. Nature, 391 (6669): 803-6. [PMID:9486652]

7. Inanobe, A; Horio, Y; Fujita, A; Tanemoto, M; Hibino, H; Inageda, K; Kurachi, Y. (1999) Molecular cloning and characterization of a novel splicing variant of the Kir3.2 subunit predominantly expressed in mouse testis. J. Physiol. (Lond.), 521 Pt 1: 19-30. [PMID:10562331]

8. Inanobe, A; Yoshimoto, Y; Horio, Y; Morishige, KI; Hibino, H; Matsumoto, S; Tokunaga, Y; Maeda, T; Hata, Y; Takai, Y; Kurachi, Y. (1999) Characterization of G-protein-gated K+ channels composed of Kir3.2 subunits in dopaminergic neurons of the substantia nigra. J. Neurosci., 19 (3): 1006-17. [PMID:9920664]

9. Isomoto, S; Kondo, C; Takahashi, N; Matsumoto, S; Yamada, M; Takumi, T; Horio, Y; Kurachi, Y. (1996) A novel ubiquitously distributed isoform of GIRK2 (GIRK2B) enhances GIRK1 expression of the G-protein-gated K+ current in Xenopus oocytes. Biochem. Biophys. Res. Commun., 218 (1): 286-91. [PMID:8573147]

10. Jelacic, TM; Kennedy, ME; Wickman, K; Clapham, DE. (2000) Functional and biochemical evidence for G-protein-gated inwardly rectifying K+ (GIRK) channels composed of GIRK2 and GIRK3. J. Biol. Chem., 275 (46): 36211-6. [PMID:10956667]

11. Karschin, C; Dissmann, E; Stühmer, W; Karschin, A. (1996) IRK(1-3) and GIRK(1-4) inwardly rectifying K+ channel mRNAs are differentially expressed in the adult rat brain. J. Neurosci., 16 (11): 3559-70. [PMID:8642402]

12. Kobayashi, T; Ikeda, K; Ichikawa, T; Abe, S; Togashi, S; Kumanishi, T. (1995) Molecular cloning of a mouse G-protein-activated K+ channel (mGIRK1) and distinct distributions of three GIRK (GIRK1, 2 and 3) mRNAs in mouse brain. Biochem. Biophys. Res. Commun., 208 (3): 1166-73. [PMID:7702616]

13. Kobayashi, T; Ikeda, K; Kojima, H; Niki, H; Yano, R; Yoshioka, T; Kumanishi, T. (1999) Ethanol opens G-protein-activated inwardly rectifying K+ channels. Nat. Neurosci., 2 (12): 1091-7. [PMID:10570486]

14. Kobayashi, T; Ikeda, K; Kumanishi, T. (2000) Inhibition by various antipsychotic drugs of the G-protein-activated inwardly rectifying K(+) (GIRK) channels expressed in xenopus oocytes. Br. J. Pharmacol., 129 (8): 1716-22. [PMID:10780978]

15. Kobayashi, T; Washiyama, K; Ikeda, K. (2003) Inhibition of G protein-activated inwardly rectifying K+ channels by fluoxetine (Prozac). Br. J. Pharmacol., 138 (6): 1119-28. [PMID:12684268]

16. Kobayashi, T; Washiyama, K; Ikeda, K. (2004) Inhibition of G protein-activated inwardly rectifying K+ channels by various antidepressant drugs. Neuropsychopharmacology, 29 (10): 1841-51. [PMID:15150531]

17. Kofuji, P; Davidson, N; Lester, HA. (1995) Evidence that neuronal G-protein-gated inwardly rectifying K+ channels are activated by G beta gamma subunits and function as heteromultimers. Proc. Natl. Acad. Sci. U.S.A., 92 (14): 6542-6. [PMID:7604029]

18. Kofuji, P; Hofer, M; Millen, KJ; Millonig, JH; Davidson, N; Lester, HA; Hatten, ME. (1996) Functional analysis of the weaver mutant GIRK2 K+ channel and rescue of weaver granule cells. Neuron, 16 (5): 941-52. [PMID:8630252]

19. Kuzhikandathil, EV; Oxford, GS. (2002) Classic D1 dopamine receptor antagonist R-(+)-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride (SCH23390) directly inhibits G protein-coupled inwardly rectifying potassium channels. Mol. Pharmacol., 62 (1): 119-26. [PMID:12065762]

20. Lesage, F; Duprat, F; Fink, M; Guillemare, E; Coppola, T; Lazdunski, M; Hugnot, JP. (1994) Cloning provides evidence for a family of inward rectifier and G-protein coupled K+ channels in the brain. FEBS Lett., 353 (1): 37-42. [PMID:7926018]

21. Lesage, F; Guillemare, E; Fink, M; Duprat, F; Heurteaux, C; Fosset, M; Romey, G; Barhanin, J; Lazdunski, M. (1995) Molecular properties of neuronal G-protein-activated inwardly rectifying K+ channels. J. Biol. Chem., 270 (48): 28660-7. [PMID:7499385]

22. Lewohl, JM; Wilson, WR; Mayfield, RD; Brozowski, SJ; Morrisett, RA; Harris, RA. (1999) G-protein-coupled inwardly rectifying potassium channels are targets of alcohol action. Nat. Neurosci., 2 (12): 1084-90. [PMID:10570485]

23. Liao, YJ; Jan, YN; Jan, LY. (1996) Heteromultimerization of G-protein-gated inwardly rectifying K+ channel proteins GIRK1 and GIRK2 and their altered expression in weaver brain. J. Neurosci., 16 (22): 7137-50. [PMID:8929423]

24. Morishige, K; Inanobe, A; Yoshimoto, Y; Kurachi, H; Murata, Y; Tokunaga, Y; Maeda, T; Maruyama, Y; Kurachi, Y. (1999) Secretagogue-induced exocytosis recruits G protein-gated K+ channels to plasma membrane in endocrine cells. J. Biol. Chem., 274 (12): 7969-74. [PMID:10075694]

25. Murer, G; Adelbrecht, C; Lauritzen, I; Lesage, F; Lazdunski, M; Agid, Y; Raisman-Vozari, R. (1997) An immunocytochemical study on the distribution of two G-protein-gated inward rectifier potassium channels (GIRK2 and GIRK4) in the adult rat brain. Neuroscience, 80 (2): 345-57. [PMID:9284339]

26. Navarro, B; Kennedy, ME; Velimirovíc, B; Bhat, D; Peterson, AS; Clapham, DE. (1996) Nonselective and G betagamma-insensitive weaver K+ channels. Science, 272 (5270): 1950-3. [PMID:8658170]

27. Patil, N; Cox, DR; Bhat, D; Faham, M; Myers, RM; Peterson, AS. (1995) A potassium channel mutation in weaver mice implicates membrane excitability in granule cell differentiation. Nat. Genet., 11 (2): 126-9. [PMID:7550338]

28. Peleg, S; Varon, D; Ivanina, T; Dessauer, CW; Dascal, N. (2002) G(alpha)(i) controls the gating of the G protein-activated K(+) channel, GIRK. Neuron, 33 (1): 87-99. [PMID:11779482]

29. Saitoh, O; Kubo, Y; Miyatani, Y; Asano, T; Nakata, H. (1997) RGS8 accelerates G-protein-mediated modulation of K+ currents. Nature, 390 (6659): 525-9. [PMID:9394004]

30. Schoots, O; Wilson, JM; Ethier, N; Bigras, E; Hebert, TE; Van Tol, HH. (1999) Co-expression of human Kir3 subunits can yield channels with different functional properties. Cell. Signal., 11 (12): 871-83. [PMID:10659995]

31. Signorini, S; Liao, YJ; Duncan, SA; Jan, LY; Stoffel, M. (1997) Normal cerebellar development but susceptibility to seizures in mice lacking G protein-coupled, inwardly rectifying K+ channel GIRK2. Proc. Natl. Acad. Sci. U.S.A., 94 (3): 923-7. [PMID:9023358]

32. Slesinger, PA; Patil, N; Liao, YJ; Jan, YN; Jan, LY; Cox, DR. (1996) Functional effects of the mouse weaver mutation on G protein-gated inwardly rectifying K+ channels. Neuron, 16 (2): 321-31. [PMID:8789947]

33. Stoffel, M; Tokuyama, Y; Trabb, JB; German, MS; Tsaar, ML; Jan, LY; Polonsky, KS; Bell, GI. (1995) Cloning of rat KATP-2 channel and decreased expression in pancreatic islets of male Zucker diabetic fatty rats. Biochem. Biophys. Res. Commun., 212 (3): 894-9. [PMID:7626127]

34. Suda, S; Nibuya, M; Suda, H; Takamatsu, K; Miyazaki, T; Nomura, S; Kawai, N. (2002) Potassium channel mRNAs with AU-rich elements and brain-specific expression. Biochem. Biophys. Res. Commun., 291 (5): 1265-71. [PMID:11883954]

35. Torrecilla, M; Marker, CL; Cintora, SC; Stoffel, M; Williams, JT; Wickman, K. (2002) G-protein-gated potassium channels containing Kir3.2 and Kir3.3 subunits mediate the acute inhibitory effects of opioids on locus ceruleus neurons. J. Neurosci., 22 (11): 4328-34. [PMID:12040038]

36. Wei, J; Hodes, ME; Piva, R; Feng, Y; Wang, Y; Ghetti, B; Dlouhy, SR. (1998) Characterization of murine Girk2 transcript isoforms: structure and differential expression. Genomics, 51 (3): 379-90. [PMID:9721208]

37. Weigl, LG; Schreibmayer, W. (2001) G protein-gated inwardly rectifying potassium channels are targets for volatile anesthetics. Mol. Pharmacol., 60 (2): 282-9. [PMID:11455015]

38. Wickman, K; Pu, WT; Clapham, DE. (2002) Structural characterization of the mouse Girk genes. Gene, 284 (1-2): 241-50. [PMID:11891065]

39. Yamakura, T; Lewohl, JM; Harris, RA. (2001) Differential effects of general anesthetics on G protein-coupled inwardly rectifying and other potassium channels. Anesthesiology, 95 (1): 144-53. [PMID:11465552]

40. Yoshimoto, Y; Fukuyama, Y; Horio, Y; Inanobe, A; Gotoh, M; Kurachi, Y. (1999) Somatostatin induces hyperpolarization in pancreatic islet alpha cells by activating a G protein-gated K+ channel. FEBS Lett., 444 (2-3): 265-9. [PMID:10050772]

41. Zhou, W; Arrabit, C; Choe, S; Slesinger, PA. (2001) Mechanism underlying bupivacaine inhibition of G protein-gated inwardly rectifying K+ channels. Proc. Natl. Acad. Sci. U.S.A., 98 (11): 6482-7. [PMID:11353868]

To cite this database page, please use the following:

John P. Adelman, David E. Clapham, Hiroshi Hibino, Atsushi Inanobe, Lily Y. Jan, Andreas Karschin, Yoshihiro Kubo, Yoshihisa Kurachi, Michel Lazdunski, Takashi Miki, Colin G. Nichols, Wade L. Pearson, Susumu Seino, Carol A. Vandenberg.
Inwardly rectifying potassium channels: Kir3.2. Last modified on 08/11/2011. Accessed on 23/05/2013. IUPHAR database (IUPHAR-DB), http://www.iuphar-db.org/DATABASE/ObjectDisplayForward?objectId=435.


Contact us | Print | Back to top | Help